Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98.4M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
-1.99M
-
Total reported value, excl. options
-
$108M
-
Value change
-
-$13.6M
-
Number of buys
-
26
-
Number of sells
-
-29
-
Price
-
$4.48
Significant Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) as of Q1 2022
70 filings reported holding PSTX - Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 98.4M outstanding shares and own 24.57% of the company stock.
Largest 10 shareholders include FMR LLC (9.38M shares), Pentwater Capital Management LP (4.97M shares), BlackRock Inc. (2.47M shares), VANGUARD GROUP INC (1.45M shares), Aisling Capital Management LP (1.04M shares), MILLENNIUM MANAGEMENT LLC (835K shares), STATE STREET CORP (532K shares), GEODE CAPITAL MANAGEMENT, LLC (503K shares), JPMORGAN CHASE & CO (319K shares), and Rock Springs Capital Management LP (290K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.